Patents by Inventor Svenja Warnecke

Svenja Warnecke has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140296341
    Abstract: The present invention relates to formulations comprising a solid dispersion product of an active agent having at least one of a hydrogen bond donor moiety (e.g. ibuprofen, fenofibric acid or naproxen) and a proton donor moiety and a pharmaceutically acceptable polyvinyllactam polyvinylacetate poly(alkylene glycol) graft copolymer, and to methods for preparing such formulations.
    Type: Application
    Filed: September 21, 2012
    Publication date: October 2, 2014
    Inventors: Samuel Kyeremateng, Gerd Woehrle, Svenja Warnecke, Simon Kullmann, Ullrich Westedt, Jürgen Weis
  • Patent number: 8629265
    Abstract: The invention relates to a method for producing phosphate-bridged nucleoside conjugates. In the method a nucleophile is first dissolved in a non-aqueous solvent and dried, and a cyclosaligenyl phosphate compound is subsequently added to the solution.
    Type: Grant
    Filed: August 6, 2009
    Date of Patent: January 14, 2014
    Assignee: Universitaet Hamburg
    Inventors: Chris Meier, Saskia Wolf, Svenja Warnecke
  • Publication number: 20110137023
    Abstract: The invention relates to a method for producing phosphate-bridged nucleoside conjugates. In the method a nucleophile is first dissolved in a non-aqueous solvent and dried, and a cyclosaligenyl phosphate compound is subsequently added to the solution.
    Type: Application
    Filed: August 6, 2009
    Publication date: June 9, 2011
    Applicant: Universitaet Hamburg
    Inventors: Chris Meier, Saskia Wolf, Svenja Warnecke